Wenbin Li

1.1k total citations
35 papers, 685 citations indexed

About

Wenbin Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wenbin Li has authored 35 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Wenbin Li's work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Lung Cancer Research Studies (7 papers). Wenbin Li is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Lung Cancer Research Studies (7 papers). Wenbin Li collaborates with scholars based in China, United States and Hong Kong. Wenbin Li's co-authors include Jianming Ying, Lei Guo, Shugeng Gao, Tian Qiu, Yun Ling, Jing Zhang, Peng Song, Ling Shan, Weihua Li and Shannon Chuai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Oncotarget.

In The Last Decade

Wenbin Li

32 papers receiving 678 citations

Peers

Wenbin Li
Wenbin Li
Citations per year, relative to Wenbin Li Wenbin Li (= 1×) peers Francisco Gimeno-Valiente

Countries citing papers authored by Wenbin Li

Since Specialization
Citations

This map shows the geographic impact of Wenbin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Li more than expected).

Fields of papers citing papers by Wenbin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Li. The network helps show where Wenbin Li may publish in the future.

Co-authorship network of co-authors of Wenbin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbin Li. A scholar is included among the top collaborators of Wenbin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbin Li. Wenbin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yi, et al.. (2025). Extrachromosomal circular DNA: enlightenment to widespread clinical application. SHILAP Revista de lepidopterología. 4(1).
2.
Huang, Yan, et al.. (2025). Developing a ceRNA-based lncRNA-miRNA-mRNA regulatory network to uncover roles in skeletal muscle development. Frontiers in Bioinformatics. 4. 1494717–1494717.
3.
Huang, Ying, Ting Bao, Tao Zhang, et al.. (2023). Machine Learning Study of SNPs in Noncoding Regions to Predict Non-small Cell Lung Cancer Susceptibility. Clinical Oncology. 35(11). 701–712. 2 indexed citations
4.
Li, Yan, Wenbin Li, Jiali Mu, et al.. (2023). Clinicopathological practice in the differential diagnosis of mucoepidermoid carcinoma from neoplasms with mucinous component. Chronic Diseases and Translational Medicine. 9(1). 29–38. 6 indexed citations
5.
Li, Wenbin, Xin Yi, Leming Shi, et al.. (2023). Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency. Genomics Proteomics & Bioinformatics. 21(5). 962–975. 5 indexed citations
6.
Li, Wenbin, Xintong Wang, Lei Guo, et al.. (2023). Identification of MKI67, TPR, and TCHH Mutations as Prognostic Biomarkers for Patients With Defective Mismatch Repair Colon Cancer Stage II/III. Diseases of the Colon & Rectum. 66(11). 1481–1491. 3 indexed citations
7.
Song, Peng, Wenbin Li, Zhirong Qian, et al.. (2022). Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma. Cancer Immunology Immunotherapy. 71(10). 2341–2354. 34 indexed citations
8.
Chen, Yingtai, Jianhua Yin, Lulu Zhao, et al.. (2022). Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing. Journal of Translational Medicine. 20(1). 563–563. 14 indexed citations
9.
Song, Peng, Shun Wang, Zhirong Qian, et al.. (2022). A Pan-Cancer Analysis of the Oncogenic Role of WD Repeat Domain 74 in Multiple Tumors. Frontiers in Genetics. 13. 860940–860940. 1 indexed citations
11.
Li, Wenbin, Jing Zhang, Zhijie Wang, et al.. (2021). Guidelines for clinical practice of ALK fusion detection in non-small-cell lung cancer: a proposal from the Chinese RATICAL study group. SHILAP Revista de lepidopterología. 1(4). 123–131. 7 indexed citations
12.
Wang, Xiaohui, Zheng Li, Hao Zhao, et al.. (2020). Construction and Analysis of the Tumor-Specific mRNA–miRNA–lncRNA Network in Gastric Cancer. Frontiers in Pharmacology. 11. 1112–1112. 35 indexed citations
13.
Li, Weihua, Yutao Liu, Wenbin Li, Li Chen, & Jianming Ying. (2020). Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC. Journal of Thoracic Oncology. 15(7). 1223–1231. 55 indexed citations
14.
Li, Wenbin, Yue Zhu, Kelin Zhang, et al.. (2020). PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. Experimental & Molecular Medicine. 52(3). 409–422. 30 indexed citations
15.
Hui, Zhouguang, Zitong Zhao, Yueming Zhang, et al.. (2019). PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population. Diagnostic Pathology. 14(1). 6–6. 31 indexed citations
16.
Li, Yan, Tongtong Zhang, Jing Zhang, et al.. (2018). Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants. Lung Cancer. 118. 128–133. 44 indexed citations
17.
Li, Yan, Lianju Gao, Di Ma, et al.. (2018). Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomas. Lung Cancer. 122. 113–119. 19 indexed citations
18.
Sun, Yongkun, Lin Yang, Chengfeng Wang, et al.. (2017). Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection. Oncotarget. 8(43). 75186–75194. 5 indexed citations
19.
Li, Wenbin, Jing Zhang, Lei Guo, et al.. (2016). Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment. Journal of Thoracic Oncology. 12(1). 94–101. 42 indexed citations
20.
Sun, Mengyang, et al.. (2012). Analysis of Gene Expression Underlying Soybean Isoflavone Synthesis Relative Enzymes at Different Growth Stages. Dadou kexue. 31(6). 887–893. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026